6Gecelter G, Fahoum B, Gardezi S, et al. Abdominal compartment syndrome in severe acute pancreatitis:an indication for a decompressing laparotomy [ J ]. Dig Surg,2002,19 (5) :402
7Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis : characteristics of a new subgroup [ J ]. Pancreas ,2001, 22(3) :274
二级参考文献13
1[1]Johnson DC,Stephens DH,Sarr MG.CT of acute pancreatitis correlation between lack of contrast enhancement and pancreatic necrosis.A.J.R,1991,156:93-96.
2Kylanpaa A,Back ML, Takala A, et al. Cellular markers of systemic inflammation and immunesuppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol,2001,36(10): 1100.
3Arnalich F, Garcia-Palomero E, Lopez J, et al. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis.Infection And Immunity,2000,68(4):1942-1945.
4Muller JM, Ziegler-Hettbrock HW, Baeuerle PA. Nuclear factor kappaB, a mediator of Lipopolysaccaride effects. Immunobiol,1993,187(3):233-256.
5Rau B, Steinbach G, et al. Clinical value of lipopolysaccharide-binding protein (LBP)determinations in acute pancreatitis. Langenbecks Arch Surg,2003,388(3): 181-188.
6Kitchens RL. Role of sCD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol,2000,74(1):61-82.
7D. L. Wyncoll. The management of severe acute necrotising pancreatitis: an evidence-based review of the literature[J] 1999,Intensive Care Medicine(2):146～156
